Clinical Trial: A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07744243) titled 'A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors' on July 30.

Brief Summary: This study is an open-label, multicenter, dose-escalation and dose-expansion, non-randomized phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advanced or metastatic urological tumors and other solid tumors.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Urological Cancer Solid Cancer

Intervention: DRUG: SI-B036

Administration by intravenous i...